Acquired myasthenia gravis: what we have learned from experimental and spontaneous animal models.
Acquired myasthenia gravis (MG) is a disorder of neuromuscular transmission in which muscle weakness results from an autoantibody mediated depletion of acetylcholine receptors (AChR) at the neuromuscular junction. Experimental autoimmune myasthenia gravis, described in rodents and rabbits, has provided a good model of the effects of the autoimmune response against AChR and has shown that the specificities of the immune response in MG are those that would be obtained by immunization with native AChR. It has provided little information, however, about what initiates and sustains the immune response in MG. Acquired MG occurs spontaneously in dogs and may be the most common neuromuscular disorder that can be diagnosed in this species. As in human MG, an autoimmune response against AChR has been demonstrated and AChR autoantibodies have been implicated in the pathogenesis. The variability in clinical presentation, methods of diagnosis, and occurrence with other autoimmune diseases and neoplasia are identical to that of humans. Future studies of spontaneous canine autoimmune MG may provide clues to the determination of what factors initiate and sustain the autoimmune response to AChR, and in the study of specific suppression of the autoimmune response against AChR.
Shelton
G D
GD
Department of Pathology, University of California San Diego, La Jolla 92093-0612, USA. gshelton@ucsd.edu
D000818:Animals; D002371:Cat Diseases / Q000503:physiopathology; D002415:Cats; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000503:physiopathology; D004285:Dogs; D006801:Humans; D009157:Myasthenia Gravis / Q000503:physiopathology / Q000662:veterinary*; D011817:Rabbits